Drug Makers Sued Over Cholesterol Drug

Law360, New York (January 3, 2007, 12:00 AM EST) -- Pharmaceutical company Lek is suing two drug makers for alleged patent infringements in the production of blockbuster cholesterol medicine Pravachol.

Lek, a wholly-owned subsidiary of Novartis, has filed civil action against US drug maker Bristol-Myers Squibb and Watson Pharmaceuticals for willful and deliberate violation of two patents.

The suit, filed December 29, 2006 in the US District Court for the Eastern District of Texas, claims the drug makers knew, or should have known, about the patents.

The patents were issued to Lek, in May 2005 and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.